PROTOKINETIX BLOG

Find out how AAGP® is changing lives through cell survival

As we move forward with clinical research for our anti-aging glycopeptide, AAGP®, we continue to uncover new areas of opportunity for the molecule. See how AAGP® is helping to provide more hope for patients and investors in the areas of ophthalmology, transplants, dermatology and biomanufacturing.

Category:
Sort By:
Oct 30, 2020
The promise of biotechnology stocks to the average investor is the potential for blazing growth and incredible returns. But not every company pays dividends on that promise. Too many times, investors have been burned by biotech stocks that burn fast and bright before completely flaming out. What these investors are looking for is not just...Read more
Sep 21, 2020
A 2017 study from the American Optometric Association found that more than 16 million Americans are affected by dry eye disease (DED), also known as dry eye syndrome (DES), including nearly twice as many women as men. There is no single cause for eye dryness. It can be temporary or chronic and result from a...Read more
Aug 21, 2020
While there is currently no cure for diabetes, we believe our anti-aging glycopeptide, AAGP®, may be the essential link to the successful treatments of tomorrow. In preliminary testing, AAGP® has been shown to have protective properties that could help with the causes and consequences of this difficult disease. If you are interested in getting involved in...Read more
Jul 20, 2020
For anyone living with Type 1 diabetes, there is no doubt it is a challenging illness. Type 1 diabetes occurs at no fault of the patient, but unfortunately, there is no known cause or cure. ProtoKinetix researchers are actively exploring the potential for our anti-aging glycopeptide, AAGP®, to make better treatments possible. Continue reading to learn...Read more
Jul 14, 2020
When you are diagnosed with diabetes, you might initially feel overwhelmed and helpless. This chronic condition isn’t easy to live with all the time, since there are physical side effects of diabetes, as well as emotional and mental effects. Fortunately, there is active research being done to help uncover a cure, including studies conducted by...Read more
Jul 13, 2020
According to the Centers for Disease Control and Prevention (CDC), there were more than 30.3 million diagnosed cases of diabetes in the U.S. in 2015, and more than 100 million Americans are living with diabetes or prediabetes. While there is currently no cure, active research is being done, including studies by ProtoKinetix principal investigators to uncover...Read more

Subscribe for updates

Get alerts about company news and key findings directly in your inbox.

Request More Information

Talk to a member of the ProtoKinetix team to learn more about our research and results.

Picture of a molecule
Picture of a molecule